782425-77-8

Upstream product

• 17879-45-7 bis-(trimethylsilyl)acetamide 
• 501-53-1 benzyl chloroformate 
• 392621-53-3 6-[(E)-2-(4-Nitrophenyl)diazenyl]-3-pyridinol 

Downstream Products

• 259799-55-8 N-[5-[(1R)-2-[N-benzyl-[(1RS)-3,3-bis(4-methoxyphenyl)-1-methylpropyl]amino]-1-(triethylsilyloxy)-ethyl]-2-(benzyloxy)phenyl]methanesulfonamide 
• 259799-07-0 N-[5-[(2S)-3-[N-benzyl-[(1RS)-3,3-bis(4-methoxyphenyl)-1-methylpropyl]amino]-2-hydroxypropoxy]-2-(benzyloxy)phenyl]methanesulfonamide 

Relevant academic research and scientific papers

Aminoalcohol derivatives and their use as beta 3 adrenergic agonists

This invention relates to new aminoalcohol derivatives or salts thereof represented by the following formula [I]: wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.